Table 2.
ATP-competitive EGFR inhibitors
Compound (reference) | Structure | Enzymatic activity | Biological activity | DMPK profile |
---|---|---|---|---|
13, JND3229 [102] |
![]() |
EGFRL858R/T790M/C797S IC50 = 5.8 nmol/L |
BaF3-EGFRL858R/T790M/C797S IC50 = 510 nmol/L BaF3-EGFRDel19/T790M/C797S IC50 = 320 nmol/L |
N/A* |
14 [103] |
![]() |
EGFRWT IC50 = 16 nmol/L EGFRL858R/T790M/C797S IC50 = 88 nmol/L |
A431 GI50 = 3600 nmol/L H1975 GI50 = 140 nmol/L |
N/A |
15 [104] |
![]() |
EGFRL858R/T790M/C797S IC50 = 8 nmol/L |
A431 EC50 = 4000 nmol/L H1975 EC50 = 400 nmol/L |
N/A |
16 [105, 106] |
![]() |
EGFRL858R/T790M/C797S IC50 = 630 nmol/L |
H1975 IC50 = 1200 nmol/L |
Liver microsomes (Human): t1/2 (min) = 66.6, CLint (mL/min/kg) = 20.8 |
17 [107] |
![]() |
EGFRWT IC50 > 1000 nmol/L EGFRL858R/T790M/C797S IC50 = 27.5 nmol/L |
BaF3-EGFRL858R/T790M/C797S IC50 = 662 nmol/L |
T1/2 (rat, minutes) = 8.36, CLint (mL/min/kg) = 297.12 |
18 [108] |
![]() |
EGFRL858R/T790M/C797S IC50 = 7.2 nmol/L |
HCC827 IC50 = 44 nmol/L H1975 IC50 = 400 nmol/L |
N/A |
19 [109, 110] |
![]() |
EGFRL858R/T790M/C797S IC50 = 18 nmol/L |
HCC827 IC50 = 0.88 nmol/L H1975 IC50 = 200 nmol/L A549 IC50 = 2910 nmol/L A431 IC50 > 10,000 nmol/L |
N/A |
20 [111] |
![]() |
EGFRL858R/T790M/C797S IC50 = 8.5 nmol/L |
EGFR CTG EC50: HCC827 IC50 < 14 nmol/L H1975 IC50 = 51 ± 19 nmol/L A431 IC50 = 1675 ± 402 nmol/L A549 IC50 = 3700 nmol/L H358 IC50 = 3700 nmol/L |
In vivo PK (mice, IP, 20 mg/kg): AUCfree (h∙ng/mL) = 8.6 t1/2 (h) = 1.2 Cmax,free (μmol/L) = 0.012 |
21 [112] |
![]() |
EGFRL858R/T790M/C797S IC50 = 3.1 nmol/L |
H1975 IC50 = 0.12 ± 0.09 μmol/L BaF3-EGFRL858R/T790M/C797S IC50 = 0.29 μmol/L BaF3-EGFR19D/T790M/C797S IC50 = 0.31 μmol/L |
N/A |
22 [113] |
![]() |
EGFRWT IC50 > 1000 nmol/L EGFRL858R/T790M/C797S IC50 = 218.3 nmol/L EGFRDel19/T790M/C797S IC50 = 15.3 nmol/L |
H1975 IC50 = 16,180 nmol/L A431 IC50 = 20,480 nmol/L BaF3-EGFRDel19/T790M/C797S IC50 = 8510 nmol/L |
N/A |
23 [114] |
![]() |
EGFRWT IC50 = 430 nmol/L EGFRDel19/T790M/C797S IC50 = 0.2 nmol/L |
BaF3-EGFRWT IC50 = 1000 nmol/L BaF3-EGFRDel19 IC50 = 180 nmol/L BaF3-EGFRDel19/T790M IC50 = 99 nmol/L BaF3-EGFRDel19/T790M/C797S IC50 = 63 nmol/L |
N/A |
24 [115] |
![]() |
N/A |
Biochemical potency: BaF3 cells IC50 < 100 nmol/L Antiproliferative activity: BaF3 cells IC50 < 100 nmol/L |
N/A |
25 [116] |
![]() |
N/A |
Antiproliferative activity: PC-9-EGFRL858R/T790M/C797S IC50 = 595.7 nmol/L PC-9-EGFRDel19/T790M/C797S IC50 = 739.9 nmol/L A549 IC50 = 2861.7 nmol/L BaF3-EGFRWT IC50 = 519.82 nmol/L BaF3-EGFRL858R/T790M/C797S IC50 = 0.16 nmol/L BaF3-EGFRDel19/T790M/C797S IC50 = 0.23 nmol/L |
N/A |
26 [117] |
![]() |
N/A |
BaF3-EGFRWT IC50 = 540 nmol/L BaF3-EGFRL858R/T790M/C797S IC50 = 48.2 nmol/L BaF3-EGFRDel19/T790M/C797S IC50 = 12 nmol/L |
N/A |
27 [115] |
![]() |
EGFRWT IC50 = 7.92 nmol/L EGFRL858R/T790M/C797S IC50 = 0.218 nmol/L EGFRDel19/T790M/C797S IC50 = 0.16 nmol/L |
Antiproliferative Activity: A431 IC50 = 154 nmol/L BaF3-EGFRDel19/T790M/C797S IC50 = 22 nmol/L |
In vivo PK (mice, per os, 15 mg/kg): AUC0-last = 57,037 (nmol/L∙h) t1/2 (h) = 10.0 Plasma (nmol/L), 2 h = 3553 Tumor (nmol/kg), 2 h = 16,667 |
28 [118] |
![]() |
EGFRWT IC50 = 3.8 nmol/L EGFRL858R/T790M/C797S IC50 = 38.1 nmol/L |
BaF3-EGFRL858R/T790M/C797S IC50 < 1000 nmol/L |
N/A |
29, UPR1444 [119] |
![]() |
EGFRWT IC50 = 30 ± 4.8 nmol/L EGFRL858R/T790M/C797S IC50 = 110 ± 33 nmol/L |
N/A | N/A |
*N/A not available